HIV: Awareness of management of occupational exposure in health care workers

Indian Journal of Medical Sciences

Volumn 57, Issue 5, 2003, Pages 192-198

  Wig, N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; BLOOD DISEASE; CONTROLLED STUDY; HEALTH EDUCATION; HEALTH PRACTITIONER; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; INFECTION; MEDICAL SPECIALIST; NEEDLESTICK INJURY; NURSING HOME; OCCUPATIONAL EXPOSURE; PHYSICIAN; PRIVATE HOSPITAL; PROPHYLAXIS; QUESTIONNAIRE; SURGEON; VACCINATION; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL;

AWARENESS; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; INDIA; OCCUPATIONAL EXPOSURE;

EID: 0642366541     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. CDC NIOSH alert: preventing needlestick injuries in health care settings. Cincinnati, OH: Department of Health and Human Services, CDC, 1999; DHHS publication no. (NIOSH) 2000-108.
2. Department of Labor, Occupational Safety and Health Administration, 29 CFR Part 1910, 1030, Occupational exposure to bloodborne pathogens; final rule, Federal Register 1991; 56, 64004-182.
3. CDC, Recommendations for prevention of HIV transmission in health-care settings, MMWR 1987; 36 (suppl. No. 2S).
4. CDC, Update universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings, MMWR 1988; 37, 377-82, 387-8.
5. Werner BG, Grady GF, Accidental hepatitis-B-surface-antigen-positive inoculations: use of e antigen to estimate infectivity. Ann Iternm Med., 1982; 97, 367-9.
6. Lanphear BP, Linnemann CC Jr., Cannon CG, DeRonde MW, Pendy L, Kerley LM. Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994; 15, 745-50.
7. Puro V, Petrosillo N, Ippolito G. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposure in health care workers. Am. J. Infect Control, 1995, 23, 273-7.
8. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers, an overview. Am. J. Med. 1997, 102, (suppl 5B), 9-15.
9. Ippolito G, Puro V, De Carli G. Italian Study Group on Occupational Risk of HIV Infection. The risk of occupational human immunodeficiency virus in health care workers. Arch Int Med. 1993, 153: 1451-8.
10. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl. J. Med. 1997; 337, 1485-90.
11. Mast ST, Woolwine JD, Gerberding JL, Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J. Infect. Dis. 1993, 168, 1589-92.
12. Grady GF, Lee VA, Prince AM, et al. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial J. Infect Dis 1978; 138: 365-38.
13. Seeff LB, Zimmerman HJ, Wright EC, et al. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis: a Veterans Administration cooperative study. Gastroenterology 1977, 72, 111-21.
14. Ruprecht RM, Bronson R. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity. DNA Cell Biol 1994; 13: 59-66.
15. Fazely F, Haseltine WA, Rodger RF, Ruprecht RM. Postexposure hemoprophylaxis with ZDV or ZDV combined with interferon-a: failure after inoculating rhesus monkeys with a high dose of SIV. J. Acquir Immune Defic Syndr 1991, 4: 1093-7.
16. Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2) J. Virol 2000; 74: 9771-5.
17. Martin LN, Murphey-Corb M, Spike KF, Davison-Fairburn B, Baskin GB. Effects of initiation of 3′-azido, 3′-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J. Infect Dis 1993; 168: 825-35.